Android app on Google Play

Cyclacel (CYCC) Pressured as Short Interest Nearly Doubles in December

December 27, 2012 1:52 PM EST Send to a Friend
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) shares are in negative territory today amid new market data showing a notable increase in short interest.

Since the last update on November 30, short interest on Cyclacel rose 92.4 percent, or 698,476 shares, to a total of 1,424,567 shares as of December 14th.

Short positions are about 18.2 percent of market float with days to cover at 2.

Shares are down about 5 percent Thursday.




You May Also Be Interested In


Related Categories

Trader Talk

Add Your Comment